HGH Fragment 176-191: fat-burning peptide without growth hormone effects
Weight Management and Healthy Lifestyle Experts

Imagine if you could take just one property from growth hormone — the ability to burn fat. And leave everything else behind: blood sugar effects, insulin resistance risk, organ growth. That's exactly what scientists did when they isolated a short fragment of the HGH molecule — amino acids 176-191.
This peptide doesn't increase IGF-1. Doesn't affect glucose. Doesn't stimulate tissue growth. It does only one thing — activates fat breakdown in fat cells. And it does this selectively, without the systemic effects of full growth hormone.
What is HGH Fragment 176-191 and where did it come from?

HGH Fragment 176-191 is a synthetic peptide consisting of 16 amino acids from the C-terminal section of human growth hormone. While full HGH contains 191 amino acids, this fragment is only positions 176 to 191 [31]. It might seem like such a small piece — how could it possibly work?
The story begins in 1993. Researchers Wu and Ng discovered something interesting: the C-terminal part of the growth hormone molecule is responsible for its lipolytic (fat-burning) activity, independent of growth effects [30]. They showed that synthetic amino acid sequence 177-191 has antilipogenic action — it inhibits fat accumulation in adipocytes.
Later, in 2000, Ng and colleagues went further. They created a modified version of the fragment — AOD-9604 — adding tyrosine to the N-terminus for stability. In studies on Zucker rats, administration of 500 mcg/kg per day for 19 days showed increased fat oxidation and body weight reduction [23].
Первинні дослідження Wu 1993 та Ng 2000 встановили що ліполітична активність HGH локалізована у C-кінцевому домені молекули і може бути відтворена синтетичним фрагментом без активації рецепторів гормону росту **[30]**.
It's important to understand: there are two related peptides. HGH Fragment 176-191 — the original sequence without modifications. AOD-9604 — its improved version with additional tyrosine for better stability and bioavailability [27]. Clinical trials predominantly used AOD-9604, while in practice the basic fragment is more commonly encountered.
How does selective lipolysis work without IGF-1?

Here's where it gets most interesting. Full growth hormone acts through specific GH receptors, which are present in virtually all body tissues — muscles, adipose tissue, liver, heart, kidneys, brain, pancreas [38]. When HGH binds to these receptors, it triggers a cascade of reactions, including IGF-1 production in the liver.
Now here's the key: HGH Fragment 176-191 doesn't bind to growth hormone receptors [14]. Its structure is too short for this. Instead, the fragment, according to preliminary data, interacts with β3-adrenergic receptors on the surface of fat cells [15].
What happens next? β3-adrenergic receptors are G-protein-coupled receptors functionally linked to Gαs and Gβγ subunits. Their stimulation increases intracellular cAMP levels through adenylyl cyclase activation [3]. cAMP, in turn, activates two main signaling pathways in adipocytes:
- PKA pathway — protein kinase A catalyzes phosphorylation of hormone-sensitive lipase (HSL) and perilipin, directly triggering lipolysis [3]
- EPAC/RAP pathway — regulates leptin secretion and adipocyte differentiation [3]
Уявіть що жирова клітина — це сейф з жиром всередині. Звичайний HGH — це майстер-ключ, який відкриває всі двері в організмі одночасно. HGH Fragment — це ключ лише від одного сейфа. Він відкриває тільки жирові клітини, не чіпаючи нічого іншого.
Hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) are the two key lipolysis enzymes. In basal state, these enzymes are in the cytosol, inactive. Upon β-receptor stimulation, PKA phosphorylates perilipin, which releases CGI-58. CGI-58 binds to ATGL and activates it. Simultaneously, PKA phosphorylates HSL, allowing it to translocate to the lipid droplet [10].
The result? Triglycerides break down into free fatty acids and glycerol, which exit the cell and can be used as fuel [14].
Even at higher doses, AOD-9604 didn't change IGF-1 levels, blood glucose, or insulin sensitivity [24]. This is a fundamental difference from full growth hormone.
What the studies showed: real numbers
Let's start with preclinical data. In a study on ob/ob mice (genetic obesity model), oral administration of AOD-9401 for 30 days produced these results: starting from day 16, weight gain in the peptide group was significantly lower compared to control. Food consumption between groups didn't differ [33].
Ex vivo adipose tissue analysis showed that AOD-9401 significantly reduced lipogenic activity and increased lipolytic activity [33]. That is, fat cells simultaneously accumulated less fat and broke it down more actively.
In Zucker rats (another obesity model), administration of 500 mcg/kg per day for 19 days increased fat oxidation and led to body weight reduction [23].
На сьогодні не існує повноцінних клінічних випробувань немодифікованого HGH Fragment 176-191 на людях. Всі дані про людей стосуються модифікованої версії AOD-9604 **[23]**. Це важливо враховувати при оцінці ефективності.
Regarding AOD-9604 — it underwent six Phase I/II clinical trials involving approximately 900 participants [21]. The safety profile was excellent: no serious adverse events related to the drug.
Side reactions were predominantly mild and comparable to placebo: headache, fatigue, injection site reactions [22]. Critically important — AOD-9604 didn't affect vital signs, ECG, glucose levels, or serum IGF-1, didn't cause insulin resistance or glucose tolerance impairment [22].
In practice, users report 10-15% fat mass reduction over 8-12 weeks at 250-500 mcg daily dosing [16]. But remember, this data isn't confirmed by controlled clinical trials.
HGH Fragment vs full HGH: why the fragment is safer?
Full growth hormone is powerful but complex tool. It affects the entire body, and not always as desired.
Порівняння HGH Fragment 176-191 та повного HGH
| Параметр | HGH Fragment 176-191 | Повний HGH (191 а.к.) |
|---|---|---|
| Молекулярна структура | 16 амінокислот, лінійна **[25]** | 191 амінокислота, 4 альфа-спіралі **[25]** |
| Вплив на IGF-1 | Відсутній**[21]** | Значне підвищення |
| Вплив на глюкозу | Відсутній**[22]** | Підвищує рівень |
| Інсулінорезистентність | Не викликає**[22]** | Може викликати **[34]** |
| Ліполіз | Активує**[33]** | Активує |
| Ріст тканин | Відсутній**[25]** | Стимулює |
| Ріст кісток | Відсутній**[26]** | Може стимулювати |
| Набряки | Не викликає**[22]** | Може викликати **[34]** |
| Безпека при діабеті | Сприятлива **[21]** | Протипоказання |
Human growth hormone or IGF-1 abuse carries serious risks. High HGH levels for extended periods can lead to irreversible acromegaly. But even smaller doses can cause complications: cardiovascular disease and diabetes [34].
Additionally, HGH reduces insulin sensitivity in a dose-dependent manner [32]. This is especially problematic for people with metabolic disorders or prediabetes.
HGH Fragment 176-191 не є ліками і не схвалений для лікування будь-яких захворювань. Інформація надана виключно для освітніх цілей. Перед застосуванням будь-яких пептидів обов'язково проконсультуйтесь зі спеціалістом.
Practical implication: the fragment can be considered for people who are contraindicated for full HGH due to metabolic risks. Although, of course, the final decision remains with the specialist after evaluating the individual situation.
HGH Fragment vs Ipamorelin + CJC-1295: when to choose what?
At first glance, all these peptides are "about the same thing" — growth hormone and weight loss. But actually they work through fundamentally different mechanisms.
HGH Fragment 176-191 is not a secretagogue. It doesn't stimulate growth hormone production in the pituitary. It mimics one specific HGH function — lipolysis — by directly interacting with fat cells [2].
Ipamorelin is a GH secretagogue that acts on ghrelin receptors (GHSR) in the pituitary gland, stimulating secretion of endogenous growth hormone [1]. It is the first selective GH secretagogue — it does not cause significant elevation of cortisol or prolactin, unlike older GHRPs [1].
CJC-1295 is an analog of growth hormone-releasing hormone (GHRH). It binds to GHRH-R receptors (class B GPCR) and activates the Gs/cAMP/PKA signaling pathway in the pituitary gland, stimulating release of GH and IGF-1 [12]. DAC (drug affinity complex) modification extends the half-life.
Studies have shown that CJC-1295 stimulates a 4-fold increase in GH levels when administered to rats [11]. In phase 1 clinical trials in healthy adults, sustained elevation of GH and IGF-1 secretion was observed [1].
Вибір пептиду залежно від цілі
| Ціль | Рекомендований вибір | Чому |
|---|---|---|
| Чистий ліполіз | HGH Fragment 176-191 | Селективна дія тільки на жирові клітини |
| Системний anti-aging | Ipamorelin + CJC-1295 | Комплексна стимуляція GH-осі |
| Відновлення м'язів | Ipamorelin + CJC-1295 | IGF-1 стимулює м'язовий синтез |
| Покращення сну | Ipamorelin + CJC-1295 | GH секретується вночі |
| Метаболічні порушення | HGH Fragment 176-191 | Не впливає на глюкозу та інсулін |
| Мінералізація кісток | Ipamorelin + CJC-1295 | Ipamorelin збільшує BMC **[1]** |
Interesting nuance: in studies on female rats, Ipamorelin and GH-releasing peptide-6 increased bone mineral content [1]. HGH Fragment doesn't have this effect — it's too selective.
Therefore, if your only goal is fat mass reduction without any other effects — HGH Fragment would be a more logical choice. However, if you need comprehensive anti-aging effects with improved skin quality, sleep, recovery — the combination of Ipamorelin + CJC-1295 will work more broadly.
HGH Fragment 176-191 protocol: how to use correctly

Let's move to practice. Based on data from research clinics and available publications, a typical protocol looks like this:
Dosage
Standard dose for research of fat-burning potential: 250-500 mcg per day [17]. Beginners are recommended to start at the lower end — 250 mcg, gradually increasing if needed.
Some protocols involve splitting the daily dose into two administrations: morning and evening [18]. This helps maintain more stable peptide levels in the blood.
Timing of administration
Key point — on empty stomach. HGH Fragment 176-191 is usually administered on empty stomach:
- If once daily: morning, at least one hour before breakfast [17]
- If twice daily: second dose in evening, several hours after last meal [17]
Why on empty stomach? Insulin suppresses lipolysis. When you eat, insulin levels rise, and this can reduce peptide effectiveness.
Оптимальний час для ін'єкції — перед ранковим кардіо натще або перед сном (через 3-4 години після вечері). Саме в ці моменти рівень інсуліну найнижчий, а ліполіз найактивніший.
Method of administration
Subcutaneous injection is the most common method [16]. To avoid tissue damage and peptide accumulation in one area, it's important to rotate injection sites [16]. Typical areas: abdomen (5 cm from navel), thighs, arms.
Course duration
Typical course: 8-12 weeks [23].
After course completion, a 4-6 week break is recommended before the next cycle. This allows the body to "reset" and maintain receptor sensitivity.
What to expect by weeks
- Weeks 1-2: Usually no noticeable changes. Body adapts.
- Weeks 3-4: Some notice slight fat reduction in problem areas, improved definition.
- Weeks 5-8: With proper caloric deficit and training — more noticeable subcutaneous fat reduction.
- Weeks 9-12: Maximum course results.
Important: HGH Fragment isn't a magic wand. It works in synergy with proper nutrition and physical activity. Without caloric deficit, there won't be significant results.
HGH Fragment 176-191 in DOZA catalog
Synergy with Mounjaro and other products

If you are already on a weight loss program with Mounjaro or similar GLP-1 agonists, HGH Fragment can be an interesting addition — especially during plateau phase.
When to consider adding HGH Fragment
After 12+ weeks on Mounjaro, when initial dynamics slow down. GLP-1 agonists work primarily through appetite suppression and gastric emptying delay. HGH Fragment works through a different mechanism — direct lipolysis activation. These are potentially complementary approaches.
Synergy with CJC-1295
Interesting option: combining HGH Fragment with CJC-1295. The fragment provides selective lipolysis, while CJC-1295 provides systemic support for the GH axis for better recovery and sleep quality [2]. Some protocols include:
- HGH Fragment in morning on empty stomach (for lipolysis)
- CJC-1295 in evening (for nighttime GH peak)
Synergy with caffeine
Pre-workout activation: caffeine itself stimulates β-adrenergic receptors and increases catecholamine levels. Theoretically, this could potentiate HGH Fragment effects. Practical protocol: HGH Fragment 30-60 minutes before fasted training, black coffee or caffeine tablet.
Спеціаліст DOZA допоможе підібрати оптимальний протокол
Потрібна консультація?What NOT to combine
Don't combine HGH Fragment with full HGH — there's no point. Full growth hormone already contains this amino acid sequence. You'd just be wasting money without additional benefit.
Side effects and safety: what's important to know
One of the main advantages of HGH Fragment is its safety profile. Most users report minimal side effects at standard doses [24].
Possible reactions
Mild and rare [24]:
- Redness or itching at injection site
- Mild headache
- Fatigue
These effects usually pass within the first days of use.
What HGH Fragment does NOT cause (unlike full HGH)
- Fluid retention and edema [22]
- Insulin resistance [22]
- Glucose level elevation [22]
- IGF-1 changes [21]
- Carpal tunnel syndrome
- Acromegaly
У шести клінічних випробуваннях із внутрішньовенним та пероральним дозуванням AOD-9604 не змінював життєві показники, ЕКГ, рівень глюкози або IGF-1 у сироватці. Препарат не викликав інсулінорезистентності чи порушення толерантності до глюкози **[22]**.
Contraindications
- Pregnancy and lactation
- Active oncological diseases
- Individual intolerance
- Age under 18
Is blood work monitoring needed?
Since HGH Fragment doesn't affect glucose, IGF-1, and other hormones, extensive monitoring is usually not required. However, basic general health monitoring never hurts — especially if you're combining several peptides.
For those with type 2 diabetes: the fragment appears to be a safer choice compared to full HGH precisely due to lack of glucose metabolism effects [21]. But definitely discuss this with your doctor.
Practical issues: storage and reconstitution
Storage
- Lyophilized powder: in refrigerator (2-8°C), up to 24 months
- After reconstitution: in refrigerator, use within 4-6 weeks
- Don't freeze solution
- Protect from direct light
Reconstitution
Typical solvent — bacteriostatic water. Add slowly, along vial wall, don't shake. Gently swirl until completely dissolved.
Calculation example:
- 5 mg peptide vial
- Add 2 ml bacteriostatic water
- Get concentration 2.5 mg/ml (or 2500 mcg/ml)
- For 250 mcg dose need 0.1 ml (10 units on insulin syringe)
HGH Fragment 176-191 in DOZA catalog
If you are planning an Ipamorelin + CJC-1295 protocol alongside HGH Fragment — Buy Ipamorelin in Ukraine and Buy CJC-1295 in Ukraine can be purchased directly through DOZA: both peptides from PeptoLabs, purity ≥ 99%, verified serial number, thermal box 2–8 °C. Express delivery Kyiv/Lviv/Dnipro in 1–2 hours or Nova Poshta 1–2 days throughout Ukraine. Before combined protocol — free consultation with DOZA specialist.
Summary: who is HGH Fragment 176-191 suitable for?
HGH Fragment 176-191 is a narrowly focused tool for one specific task: activating lipolysis in fat cells without systemic growth hormone effects. It doesn't increase IGF-1, doesn't affect glucose levels, doesn't stimulate organ or bone growth.
Who might find this useful:
- People in cutting or cutting-phase stage
- Those who reached plateau on GLP-1 agonists and seek additional tools
- People with metabolic disorders for whom full HGH is contraindicated
- Those who want selective action without affecting other body systems
Who this is NOT suitable for:
- If comprehensive anti-aging effects needed (better Ipamorelin + CJC-1295)
- If expecting muscle growth (fragment doesn't do this)
- If not ready to maintain caloric deficit and exercise
The scientific basis for HGH Fragment is based primarily on preclinical studies and AOD-9604 data. There are no full clinical trials of unmodified fragment in humans yet [23]. This is important to consider when forming expectations.
If the topic interests you and you want to understand whether this peptide is right for you — contact a DOZA specialist for individual consultation.
Напишіть у Telegram для безкоштовної консультації
Готові почати курс HGH Fragment?Where to buy
DOZA supplies the products mentioned in this article with an official cold chain and 24/7 specialist support:
- Buy Mounjaro in Ukraine — DOZA catalog with all 6 doses (2.5–15 mg) and official 24h cold-chain delivery. Current Mounjaro prices.
📚 Sources & references
- 1Fragment 176-191 & CJC-1295 & Ipamorelin Blend Studies
Дані про Ipamorelin та його вплив на мінеральний вміст кісток, порівняння механізмів дії пептидів
- 2Fragment 176-191 & CJC-1295 & Ipamorelin - Core Peptides
Порівняння механізмів дії фрагменту та GH-секретагогів
- 3JCI - β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity
Механізм дії β3-адренергічних рецепторів та сигнальний шлях PKA/HSL
- 4Reduced lipolysis response - Scientific Reports
Експресія β1 та β3 рецепторів у жировій тканині
- 5Non-adrenergic control of lipolysis - Journal of Experimental Biology
Механізми ліполізу та роль β-адренергічних рецепторів
- 6Biochemistry, Lipolysis - NCBI Bookshelf
Базовий та стимульований ліполіз, роль периліпіну, HSL та ATGL
- 7CJC-1295 Side Effects - Peptides.org
Механізм дії CJC-1295, дані про 4-кратне підвищення GH
- 8CJC-1295 GHRH-R Research
Рецепторна фармакологія CJC-1295
- 9HGH Fragment 176-191 Dosage - Peptide Calculator
Механізм дії фрагменту, відсутність зв'язування з GH-рецепторами
- 10Frag 176-191: Lipolytic Models - Biotech Peptides
Гіпотеза про взаємодію з β3-адренергічними рецепторами
- 11Fragment 176-191: Benefits - The Peptide Report
Протокол дозування 250-500 мкг, ротація зон ін'єкцій
- 12Fragment 176-191 Dosage Calculator - Peptides.org
Рекомендації щодо часу введення та частоти
- 13HGH Frag 176-191 Fat Loss - The Peptide Report
Типові дози для початківців та досвідчених користувачів
- 14AOD 9604 Peptide - Perfect B
6 клінічних випробувань AOD-9604, профіль безпеки, стандартний протокол
- 15Emerging Peptides in Athletic Body Recomposition
Безпека AOD-9604 у клінічних випробуваннях, відсутність впливу на IGF-1
- 16HGH Fragment 176-191 Research Evidence - PeptideInsight
Таблиця доз у передклінічних дослідженнях, Wu 1993, Ng 2000
- 17HGH Fragment 176-191 vs AOD 9604 - Edge Peptides
Порівняння побічних ефектів, механізм AOD-9604
- 18HGH and HGH Fragment Differences - UK SARMs
Порівняльна таблиця HGH vs Fragment, молекулярна структура
- 19hGH Fragment 176-191 - Peptides Calculator
Загальний опис фрагменту як ліполітичного пептиду
- 20What Is AOD-9604 - Honest Peptide
Порівняння AOD-9604 та HGH Fragment 176-191, стабільність
- 21How AOD-9604 Targets Fat Cells - BHRC
Структура AOD-9604, селективний механізм дії
- 22Human Growth Hormone Fragment 176–191 Peptide - PMC
Вплив hGH на адипозну тканину, HSL
- 23Effects of oral administration of AOD-9401 - PDF
Wu та Ng 1993 первинне дослідження
- 24Fragment 176-191 Side Effects - Peptides.org
Визначення фрагменту, C-кінцева послідовність
- 25IGF-1 LR3 vs HGH - Swolverine
Побічні ефекти HGH, інсулінорезистентність
- 26Effects of oral administration of AOD-9401 - PubMed
Дослідження на ob/ob мишах, зниження ваги без зміни споживання їжі
- 27Health risks of human growth hormone - TGA
Ризики зловживання HGH, акромегалія, діабет
- 28Human Growth Hormone - Cleveland Clinic
Механізм дії HGH через IGF-1
- 29Growth Hormone Derivative - ScienceDirect
Ізоформи GH 22 kDa та 20 kDa
- 30The Peptide Protocols - PDF
Рецептори гормону росту в тканинах організму
- 31JCI Insight - β3-Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis
in the translation but not transcription of ATGL, CGI-58, and HSL enzymes. Lower levels of ATGL and
- 32Fragment 176-191 & CJC-1295 & Ipamorelin - 12MG - Raw Amino
Raw Amino Fragment 176-191 & CJC-1295 & Ipamorelin # Fragment 176-191 & CJC-1295 & Ipamorelin – 12M
- 33Deletion of adipose triglyceride lipase abolishes blood flow increase ...
Our findings suggest a potential role of β3-AR signaling in the regulation of VAT BF via ATGL-mediat
❓ FAQ
First noticeable results typically appear at 3-4 weeks of use with proper caloric deficit and physical activity. Maximum effect is achieved by 8-12 weeks of the course. Without proper nutrition and training, there will be no significant results.
Anastasia Shapoval
Metabolic Programs and Weight Control Specialist
Article author
DOZA TeamWeight Management and Healthy Lifestyle Experts
The DOZA team of specialists with years of experience in personalized weight loss programs with Mounjaro. Every article is reviewed by experts and based on current scientific research.
About DOZA
DOZA is Ukraine's leading online medical weight-loss support service based on tirzepatide (Mounjaro) and GLP-1. Operating since 2023, 2,147+ clients, 24/7 specialist support, cold chain delivery across Ukraine.
The materials in this article are for informational purposes only. Please consult a specialist before starting any weight management program. For a free consultation message us on Telegram.
Buy Mounjaro in Ukraine
Original KwikPen by Eli Lilly — order with delivery and 24/7 specialist support
Ready to start?
Message us — a specialist will select a program for you in 5 minutes. Free of charge.
💬 Message on TelegramFree consultation • We respond 24/7